The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
(10 - 33) Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
150 jobs Number of planned job creations
Announcement Date
29 March 2007
Employment effect (start)
Foreseen end date
Description
Pharmaceutical giant GlaxoSmithKline (GSK) is expected to unveil plans today, 29 March 2007, to begin production of a new anti-cancer drug at its Cork plant which will create 150 jobs. GSK obtained approval from the US regulator, the Food and Drug Administration (FDA), for the breast cancer treatment drug Tykerb, and the company is planning to commence production of the drug at the Currabinny site near Carrigaline, where it was researched and developed. GSK already employs 1,400 people in Ireland, including between 600 and 700 people at the Co Cork site. Production of the new drug will involve a multimillion Euro investment which will create some 150 jobs. GSK's plant in Currabinny was established in 1974 and is currently the sole production site for a number of the company's top-selling drugs. The investment will be good news for both Cork and the wider economy following some setbacks and job losses in the pharmaceuticals sector.
Sources
29 March 2007: The Irish Times
Citation
Eurofound (2007), Glaxo Smith Kline, Business expansion in Ireland, factsheet number 65199, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/65199.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...
The more employee monitoring resembles surveillance – with its systematic, continuous and detailed tracking of employees' activities, behaviours or communications – the greater the potential for infringement of both privacy and data protection rights. Although the EU General Data Protection...
Since 2013, Eurofound's ERM database on restructuring-related legislation has been documenting regulatory developments in the Member States of the European Union and Norway which are explicitly or implicitly linked to anticipating and managing change. The most recent update to the...